Turn innovation into global healthcare impact

Export life science globally

Export opportunities in life science

Exporting life science solutions means operating in highly regulated markets where success depends on clinical evidence, regulatory approvals and effective market access strategies. Opportunities include:

Pharmaceuticals and advanced therapies
Growing demand for innovative treatments, vaccines and advanced therapies creates opportunities for companies to enter new markets and address future healthcare needs.
Medical technology and diagnostics
Investments in more efficient diagnostics, treatment and patient care create opportunities for companies offering medical technology and diagnostic solutions.
Biotechnology and research tools
Increased investment in research and drug development is driving demand for laboratory equipment, research platforms and specialised tools.
Digital health and connected care
Healthcare digitalisation creates opportunities for companies offering telemedicine, remote monitoring and data-driven solutions that improve access to care.
Partnerships and licensing-based business models
Licensing agreements and strategic collaborations create opportunities to access regulatory expertise, distribution channels and new markets.
Growing global demand for healthcare solutions
An ageing population, rising rates of chronic disease and increasing healthcare investment are driving long-term demand for innovative treatments, technologies and services.

Contact our teeam

Export markets

Export conditions in life science vary significantly across regions, shaped by differences in regulatory frameworks, reimbursement systems, healthcare structures and stakeholder expectations. Understanding how approval processes, market access requirements and partnership models differ is key to prioritising markets and positioning your solutions effectively. With teams on the ground, we provide insight into regulatory conditions, payer systems and local stakeholder landscapes.

Explore our market pages to better understand business opportunities, market conditions, and developments across key regions.

Common challenges

• Regulatory approval and compliance complexity
• Customs procedures and import requirements
• Reimbursement and market access barriers
• Long development and sales cycles
• Need for clinical evidence and local validation
• Building trust with partners and stakeholders

These challenges highlight the need for structured planning and market-specific strategies when expanding internationally.

How we support your export journey

Explore our offering

Market entry and prioritisation

We help you assess markets, regulatory pathways and customer segments so you can prioritise where to invest. This includes market analysis, stakeholder mapping and insights from our local teams and life science specialists, covering approval processes and market access conditions. As a result, you gain a clear view of where your solution can move forward and how to approach each market.

Go-to-market and partnerships

We support your commercial and market access approach, helping you position your offering and build partnerships needed for approval and commercialisation. Working step by step with your team, we connect you with distributors, partners and healthcare stakeholders through our networks and arrange meetings and delegations supported by industry experts. This strengthens your ability to navigate complex processes and progress in target markets.

Local presence and execution support

We support your local activities, helping you establish presence and manage ongoing market engagement. Combining local presence with global reach, our teams provide on-the-ground support including business services, regulatory guidance and stakeholder coordination. This allows you to operate effectively within local healthcare systems and build a sustainable market position.

Our latest reports & insights

All our reports

Staying competitive in a rapidly evolving ATMP market

Advanced Therapy Medicinal Products (ATMPs) are redefining modern medicine by addressing the root causes of disease through gene therapy, cell therapy, and tissue engineering. Once considered experimental, these treatments are now delivering potentially curative outcomes across oncology, rare diseases and neurological disorders.

Healthcare Insights: Morocco and Côte d’Ivoire

Healthcare systems in Morocco and Côte d’Ivoire are undergoing rapid transformation, driven by major reforms, rising demand, and expanding investment.

Pioneering climate adaptation in healthcare

The healthcare and life sciences industry is facing a dual challenge – mitigating emissions while building the climate-resilient health systems of the future. In this EGI report we explore how Swedish companies can bridge the gap and accelerate climate adaptation in overseas markets.

All our reports

Upcoming events related to life science

See more events

November 03

Logistik & Transport

Business Sweden är samarbetspartner till Svenska Mässan, där Logistik & Transport arrangeras den 3–4 november 2026 i Göteborg. Business Sweden kommer att bidra med omvärldsanalys med fokus på...

November 03 - 04, 2026

Svenska Mässan i Göteborg

November 03

Focus Mexico – SME Study Trip 2026

Följ med Business Sweden till Mexiko 3–6 november 2026 för en 4-dagars studieresa där svenska SMEs får marknadsinsikter, lokala kontakter och affärsmöjligheter.

November 03 - 06, 2026

Mexico

November 05

Swedish Country Pavilion at China International Import Expo 2026

Sweden has been invited to participate in the 9th China International Import Expo (CIIE), taking place in Shanghai from 5–10 November 2026.

November 05 - 10, 2026 5-10 November 2026

Shanghai China

See more events

How we've supported Life science companies

See more client cases

Advancing biotech innovation from Sweden

South Korean investor GemVax & Kael has reinvested in Gothenburg-based VERIGRAFT, supporting the company’s continued clinical development of personalised biological vascular grafts. The investment strengthens VERIGRAFT’s ability to pursue regulatory approval in Europe and the United States.

Cultural understanding is key for EQL pharma's success in india

With hands-on support, EQL Pharma gained valuable insights that helped the team understand diverse cultural perspectives and identify practical ways to collaborate more effectively, strengthening their operations in India.

All systems go: Sobi gets plug-and-play support in Australia

With hands-on business support, Sobi transitioned from a partner-led model to full commercial setup and market presence in Australia, establishing a subsidiary and growing a local team of 15 in just four years.

See more client cases

Looking to invest in Sweden?

Sweden offers a competitive life science ecosystem with strong research, data infrastructure and healthcare collaboration. Explore investment opportunities in pharmaceuticals, medtech and digital health innovation.

Invest in Sweden

Talk to me about life science

Senior Project Manager Mattias Gäreskog

PROGRESS BY TRADE

We help Swedish companies grow global sales and international companies invest and expand in Sweden.